The Road to Recovery in MDD: From Partial Response to Remission and Beyond

Many patients with MDD experience only partial improvement despite adequate antidepressant therapy. This session focuses on recognizing clinically meaningful residual symptoms, reviews emerging evidence for adjunctive pharmacologic options, and provides practical approaches to optimizing treatment with the goal of achieving remission and sustained recovery.

Supported by an independent educational grant from Johnson & Johnson.